Enzyme compositions and diagnostics for use in enterometabolic dysfunction
US11944668B2 · kind B2 · utility
0Cited by
2References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 23, 2017 |
| Grant date | Apr 2, 2024 |
| Priority date | — |
| Expiry date | Jan 15, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2236/37
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns the improvement of metabolic and digestive health of humans by providing diagnostic methods for enterometabolic disorders such as IBS and IBD and/or the treatment of IBS and IBD by compositions comprising enzyme rich malt extract (ERME).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.